@misc{HeinzVossLawrieetal.2016,
  author    = {Heinz, A. and Voss, M. and Lawrie, S. M. and Mishara, A. and Bauer, M. and Gallinat, J{\"u}rgen and Juckel, G. and Lang, U. and Rapp, Michael Armin and Falkai, P. and Strik, W. and Krystal, J. and Abi-Dargham, A. and Galderisi, S.},
  title     = {Shall we really say goodbye to first rank symptoms?},
  series = {European psychiatry : the journal of the Association of European Psychiatrists},
  volume    = {37},
  journal   = {European psychiatry : the journal of the Association of European Psychiatrists},
  publisher = {Elsevier},
  address   = {Paris},
  issn      = {0924-9338},
  doi       = {10.1016/j.eurpsy.2016.04.010},
  pages     = {8 -- 13},
  year      = {2016},
  abstract  = {Background: First rank symptoms (FRS) of schizophrenia have been used for decades for diagnostic purposes. In the new version of the DSM-5, the American Psychiatric Association (APA) has abolished any further reference to FRS of schizophrenia and treats them like any other "criterion A' symptom (e.g. any kind of hallucination or delusion) with regard to their diagnostic implication. The ICD-10 is currently under revision and may follow suit. In this review, we discuss central points of criticism that are directed against the continuous use of first rank symptoms (FRS) to diagnose schizophrenia.},
  language  = {en}
}